Targeted delivery of apelin using a novel extracellular vesicle platform for pulmonary arterial hypertension treatment
{{output}}
Pulmonary arterial hypertension (PAH) is a severe disease characterized by endothelial dysfunction, vascular remodeling, and pulmonary artery occlusion, culminating in right ventricular hypertrophy and heart failure. While apelin peptides are promising therape... ...
